Eric Hoste

Last week, this marvelous team celebrated 1500 liver transplantations in @uzgent. Expertise, engagement and most of all collaboration are key for success.

For World Kidney Day can we please FIX THE MATH @ISNkidneycare claims only 13m people sustain AKI annually but it's really about 100m. In the US about 11% of hospitalizations have AKI or about 90 per 10,000 person yrs. If we include AKD, rates are above 130 per 10,000 person yrs

A selection of 2023's highlighted research ! 🔝🔥🔥

🏆 Top cited @yourICM articles published this year 🥈 with 20 citations in 2023 (really close to 1st place) 🧫@EuroBact2 study on hospital‑acquired bloodstream infections in #ICU, including 2600 pts, 699 contributors from 333 ICUs/52 countries #FOAMcc 🔓 rdcu.be/c5nEP

Our new publication in @Crit_Care🍾 How often is significant mortality reduction in single-center trials replicated by subsequent multicenter trials? Even if you consider monocentric trials published in NEJM/JAMA/Lancet, the probability is only 6%😱 🔓doi.org/10.1186/s13054…

The first participant was enrolled in the LIMIT trial - RCT comparing Low and Medium Intensity CRRT. Significant step forward😀

Presented at #LIVES2023: In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia. Full AMIKINHAL trial results: nej.md/472lySJ

📣 2 major new REMAP-CAP papers were released moments ago! 📄 Intravenous #VitaminC for Patients Hospitalized with #COVID19: Two Harmonized Randomized Clinical Trials 👉 jamanetwork.com/journals/jama/… 📄 #Simvastatin in Critically Ill Patients with COVID-19 👉 nejm.org/doi/full/10.10…

Convalescent Plasma for Covid-19 ARDS decreased 28 day mortality @NEJM @ESICM

👇Free access to our methylene blue meta-analysis recently published in @JCVAonline Additional evidence in favor of multimodal vasopressor therapy✨ 🔓authors.elsevier.com/c/1hzYp3lSIPuA… #FOAMcc

Presented at #LIVES2023: In this open-label, randomized trial in patients newly receiving mechanical ventilatory support for Covid-19–associated ARDS, those who received convalescent plasma had lower 28-day mortality than those who received standard care. Full study:

🫁Convalescent plasma against COVID-19 reduced mortality in COVID-19 patients on mechanical ventilation. Proud to have been part of this Belgian PRCT run by Benoit Misset and presented at #LIVES2023 🔓tinyurl.com/yat4aru4 @ESICM @NEJM @KCEfgov @RodeKruisVL

If we can make reviewers smile😄, we will be able to smile 😊 How to deal with reviewers' comments and successful publication By @PPovoa3

RRT workshop during ESICM Lives 2023 (and the coffee break ☕️)

👏 Prof Antonio Artigas is the recipient of this year's ESICM Society Medal. He is a founding member of ESICM & his dedication & expertise over +40 years have allowed him to witness the evolution of #CriticalCare medicine & remain an active participant in its advancement.

AKI #LIVES2023 #ESICM @KatiaDonadello @EricHoste @JohnProwle: serum creatinine is an inappropriate measure in our patient cohort NB- Creatinine in Spinal Injury patients hopeless! #NeuroICM #AKI

this is a beautiful Figure @romsonnevil

The @ESICM VITAL project to improve #ICU care just launched at #LIVES2023 📢 Voice of patients & family members 🌈 Inclusion, diversity, empowerment 🤝Together, partnership, value 🛟 Alliance:collaboration 🔗 Linking: creating peer community #togetherweareICU but with patients, who are persons & family members, being part of that

Second day of @ESICM @EuroELSO #ECMO #simulation workshop is about to start here in Milan at #LIVES2023!! #simulation training tomorrow 🩸cannulation 🫁 veno-venous #ECMO & 🫀veno-arterial #ECLS scenarios ⚙️ #extracorporeal circuit & troubleshooting complications

How to use Social Media to promote your research. Great talk at #LIVES2023 by Marta Velia Antonini @FOAMecmo @ESICM